TG THERAPEUTICS, INC. — Director's Dealing 2024

Mar 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2024-03-13

Reporting Person: Lonial Sagar (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-13	Common Stock	S	5000	$15.935	Disposed	108878	Direct

Footnotes

F1: Includes shares of restricted Common Stock, which vest over various time periods.